Green Spirit Industries Inc. Completes Construction on Medicinal Cannabis Dispensary in Puerto Rico

DORADO, Puerto Rico, May 08, 2018 -- Green Spirit Industries Inc. (OTC Pink:GSRX) (“Green Spirit” or the “Company”) announced today that it has completed construction on another of its five previously announced medicinal cannabis dispensary locations in Puerto Rico.  Located in the Hato Rey district of San Juan, this dispensary will commence operations upon receipt of the requisite establishment license from the DHPR.

Green Spirit’s newest dispensary is located at Calle César González #508, Hato Rey, Puerto Riuco 00918, a heavily trafficked area that is in close proximity to a large concentration of medical facilities, most notably Clinica las Americas Medical Center and El Maestro Hospital. San Juan‘s Hato Rey district includes a mix of both residential and commercial properties and is the city’s most densely populated district. 

Like the Company’s other locations throughout Puerto Rico, this dispensary will offer patients an extensive selection of medicinal cannabis.

The Company opened its first Green Spirit RX medicinal cannabis dispensary, located in Dorado, in late March.  Green Spirit has prequalified licenses for three other dispensaries that are in various states of completion, and will commence operations at these dispensaries upon receipt of the requisite establishment licenses from the DHPR.

For more information about Green Spirit, visit the Company’s website at http://www.greenspiritrx.com/.

About Green Spirit Industries Inc.
Green Spirit Industries Inc. (OTC Pink:GSRX), through its subsidiaries, is in the business of acquiring, developing and operating retail cannabis dispensaries, and is in the process of expanding its business to include the cultivation, extraction, manufacture and delivery of cannabis and cannabinoid products.

Forward-Looking Statements                                                                                                 
This press release contains forward-looking statements. Such statements include statements regarding our expectations, hopes, beliefs or intentions regarding the future, including but not limited to statements regarding our market, strategy, competition, development plans (including acquisitions and expansion), financing, revenues, operations, and compliance with applicable laws. Forward-looking statements involve certain risks and uncertainties, and actual results may differ materially from those discussed in any such statement. Factors that could cause actual results to differ materially from such forward-looking statements include the risks described in greater detail in the following paragraphs. All forward-looking statements in this document are made as of the date hereof, based on information available to us as of the date hereof, and we assume no obligation to update any forward-looking statement except where applicable law requires us to update these statements. Market data used throughout this prospectus is based on published third party reports or the good faith estimates of management, which estimates are based upon their review of internal surveys, independent industry publications and other publicly available information.

Contact:                                
Paul Gendreau
PGPR
[email protected]
678-807-7945